TRILEPTAL

Serial Number 74519619
Registration 2186101
800

Registration Progress

Application Filed
May 2, 1994
Under Examination
Jun 6, 1995
Approved for Publication
Feb 10, 1995
Published for Opposition
Mar 14, 1995
Registered
Sep 1, 1998

Trademark Image

TRILEPTAL

Basic Information

Serial Number
74519619
Registration Number
2186101
Filing Date
May 2, 1994
Registration Date
September 1, 1998
Published for Opposition
March 14, 1995
Renewal Date
September 1, 2018
Drawing Code
1000

Status Summary

Current Status
Active
Status Code
800
Status Date
Aug 30, 2018
Registration
Registered
Classes
005

Rights Holder

Novartis Corporation

03
Address
564 Morris Avenue
Summit, NJ 07901

Ownership History

Ciba-Geigy Corporation

Original Applicant
03
Ardsley, NY

Ciba-Geigy Corporation

Owner at Publication
03
Ardsley, NY

Ciba-Geigy Corporation

Original Registrant
03
Ardsley, NY

Novartis Corporation

New Owner After Registration #1
03
Summit, NJ

Legal Representation

Attorney
Maury M. Tepper, III

USPTO Deadlines

Next Deadline
975 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 19980901)
Due Date
September 01, 2028
Grace Period Ends
March 01, 2029

Application History

36 events
Date Code Type Description Documents
Aug 30, 2018 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Aug 30, 2018 RNL2 Q REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) Loading...
Aug 30, 2018 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Aug 30, 2018 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Aug 22, 2018 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Sep 1, 2017 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Jun 27, 2009 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 27, 2009 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 26, 2008 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
Feb 26, 2008 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Feb 19, 2008 PLGL A ASSIGNED TO PARALEGAL Loading...
Feb 14, 2008 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Aug 8, 2007 CFIT O CASE FILE IN TICRS Loading...
Dec 4, 2004 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Nov 18, 2004 MAIL I PAPER RECEIVED Loading...
Feb 6, 2004 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Sep 1, 1998 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 29, 1998 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jun 12, 1998 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 8, 1998 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
May 21, 1998 IUAF S USE AMENDMENT FILED Loading...
Jan 30, 1998 EX5G S SOU EXTENSION 5 GRANTED Loading...
Dec 3, 1997 EXT5 S SOU EXTENSION 5 FILED Loading...
Jul 2, 1997 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jun 3, 1997 EXT4 S SOU EXTENSION 4 FILED Loading...
Jan 29, 1997 EX3G S SOU EXTENSION 3 GRANTED Loading...
Dec 4, 1996 EXT3 S SOU EXTENSION 3 FILED Loading...
Aug 10, 1996 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 31, 1996 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 22, 1996 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 5, 1995 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 6, 1995 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 14, 1995 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 10, 1995 NPUB O NOTICE OF PUBLICATION Loading...
Sep 16, 1994 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 16, 1994 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
anti-epileptic drug
First Use Anywhere: 19740000
First Use in Commerce: Apr 19, 1993

Classification

International Classes
005